Sumit Aggarwal is the founder of Zikani Therapeutics. Zikani Therapeutics has raised $62M in total funding. Latest round: Series A. Based in Watertown, MA.
Sumit Aggarwal is the President, Chief Executive Officer, and Director of Zikani Therapeutics, Inc., a role he has held since 2019. He also serves as President, CEO, and Director at Eloxx Pharmaceuticals, Inc. since 2021, following Eloxx's acquisition of Zikani Therapeutics. Zikani Therapeutics focuses on developing ribosome modulating agents for rare, nonsense mutation-driven diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library